disruptpress efi
Business

AstraZeneca vaccine found to be 79% effective in U.S. trial, ‘no increased risk’ of blood clots

A healthcare professional draws up a dose of the Oxford/AstraZeneca Covid-19 vaccine at the vaccination centre set up inside Brighton Centre in Brighton, southern England, on January 26, 2021.
Ben Stensall | AFP | Getty Images

LONDON — The findings of a large U.S. trial have shown that the coronavirus vaccine developed by AstraZeneca and the University of Oxford is 79% effective in preventing symptomatic illness and 100% against severe disease and hospitalization.

The results were published Monday

It comes shortly after a flurry of countries temporarily suspended use of the shot following reports of blood clots in some vaccinated people.

Germany, France, Italy and Spain are among those that have resumed use of the Oxford-AstraZeneca vaccine after Europe’s drug regulator said its initial investigation of possible side effects concluded the shot is safe and effective.

This is a developing story and will be updated shortly.

Products You May Like

Articles You May Like

Coastal Flooding Is Putting Retirement Savings At Risk
Some states require amended tax returns for $10,200 unemployment tax break refunds
Cybersecurity start-up Darktrace plans to go public in London despite Deliveroo’s IPO flop
An $11.7 Million Homage To Nature Above Sydney‘s Castle Cove
24% of unemployed workers have been jobless for over a year

Leave a Reply

Your email address will not be published. Required fields are marked *